Safinamide inhibition of in vivo glutamate release in a rat model of Parkinson's Disease

被引：0
|
作者：
Padoani, G.
Novello, S.
Pisano, C.
Caccia, C.
Melloni, E.
Vailati, S.
Keywood, C.
Morari, M.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
182
引用
收藏
页码：S81 / S82
页数：2
相关论文
共 50 条
  • [1] Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
    Pisano, Clarissa A.
    Brugnoli, Alberto
    Novello, Salvatore
    Caccia, Carla
    Keywood, Charlotte
    Melloni, Elsa
    Vailati, Silvia
    Padoani, Gloria
    Morari, Michele
    NEUROPHARMACOLOGY, 2020, 167
  • [2] Effects of nonselective inhibition of glutamate release in advanced Parkinson's disease
    Bara-Jimenez, W
    Dimitrova, T
    Sherzai, A
    Chase, T
    MOVEMENT DISORDERS, 2004, 19 : S269 - S269
  • [3] An in vivo rat model for Parkinson's disease
    Loopuijt, LD
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 318 - 318
  • [4] Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia
    Morari, Michele
    Brugnoli, Alberto
    Pisano, Clarissa Anna
    Novello, Salvatore
    Caccia, Carla
    Melloni, Elsa
    Padoani, Gloria
    Vailati, Silvia
    Sardina, Marco
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 364 (02): : 198 - 206
  • [5] Safinamide in Parkinson's disease
    Marti-Andres, G.
    Jimenez-Bolanos, R.
    Arbelo-Gonzalez, J.
    Pagonabarraga-Mora, J.
    Duran-Herrera, C.
    Carmona-Abellan, M.
    Luquin-Puido, R.
    MOVEMENT DISORDERS, 2018, 33 : S12 - S12
  • [6] SAFINAMIDE FOR SYMPTOMS OF PARKINSON'S DISEASE
    Mueller, T.
    DRUGS OF TODAY, 2015, 51 (11) : 653 - 659
  • [7] Safinamide for the treatment of Parkinson's disease
    Kandadai, Rukmini Mridula
    Jabeen, Shaik Afshan
    Kanikannan, Meena A.
    Borgohain, Rupam
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 747 - 759
  • [8] Safinamide: A Review in Parkinson's Disease
    Blair, Hannah A.
    Dhillon, Sohita
    CNS DRUGS, 2017, 31 (02) : 169 - 176
  • [9] Safinamide for the treatment of Parkinson's disease
    Dezsi, Livia
    Vecsei, Laszlo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 729 - 742
  • [10] Safinamide in the treatment of Parkinson's disease
    Mueller, Thomas
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2020, 10 (04) : 195 - 204
12345